Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Objective: Minimally invasive modality, such radiofrequency (RFA), was reported to be an effective and save option to treat the
nodular goiter and can be used to prevent the development of thyroid cancer. Our study aimed to assess the effectiveness of RFA
for treatment of thyroid nodules.
Material & Methods: During RFA procedure, thermal energy was delivered through a bipolar applicator with a diameter of 1.3
mm (18-gauge), a shaft length of 102 mm and an active tip length of 10 mm. In total, there were 81 samples of resected thyroid
tissue (44 of papillary thyroid carcinoma, 16 of follicular adenoma and 21 of adenomatous colloid goiter).
Results: Primary size in our series of nodules varied from 4.2 to 27.1 mm; accordingly, lesion size fluctuated from 2.2 to 14.1 mm and
nodule size reduction changed from 22.4 to 100%. Therefore, in this range of nodules with every additional mm of primary nodule
size we detected decreasing of lesion size by 2.4% (p<0.001). In addition, nodule size reduction in papillary thyroid carcinoma was
in average, 8% less than in parenchymal or colloid benign thyroid nodules of the same primary size. Microscopic changes varied
but shrinkage of follicles, necrotic foci, karyolysis or karyopyknosis of thyrocytes, connective tissue thickening and contracture of
blood vessel were usual. RFA effectively induced lesions of similar size as in parenchymal as in colloid nodules. Substantial nodule
size reduction was achieved albeit differences in consistency and or malignancy of the thyroid nodules. Multisession approach and
call for pre-treatment to increase the electrical conductivity and radio-frequency influence need further consideration.
Biography
Daniel Igor Branovan is the Founder and President of Project Chernobyl, un-accredited not-for-profit international organization based in New York. He is a US-trained Head and Neck Surgeon and serves as Director and Chair of the New York Ear, Nose and Throat Institute. He has received his Medical training at Stanford University School of Medicine and Harvard University School of Public Health.